Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection.

Sofía De la VillaSergio HerreroPatricia MuñozCarmen RodríguezMaricela ValerioElena ReigadasAna Álvarez-UríaLuis AlcaláMercedes MarínMaría OlmedoMartha KestlerEsther ChamorroEmilio Bouza

Published in: Open forum infectious diseases (2023)

BZX and FMT were infrequently used in real-world practice. Both treatments had similar effectiveness in preventing CDI recurrence despite their application to different populations.

Keyphrases

clostridium difficile
randomized controlled trial
primary care
healthcare
systematic review
free survival
genetic diversity